Vermillion Announces Issuance Of Patent For Peripheral Artery Disease

Links shared publicly online about this topic.

584
total visits

Vermillion Announces Issuance Of Patent For Peripheral Artery Disease

Vermillion, Inc. (Nasdaq: VRML), a molecular diagnostics company, announced that the United States Patent and Trademark Office (USPTO) has issued patent number 7,867,719 entitled Beta-2 microglob

View full resource at medicalnewstoday.com

Tags: Circulation, Circulatory Disorders, Peripheral Artery Disease, Thrombotic Event, Disease and Condition, disease

Most Recently Shared on January 14, 2011 at 2:46 am By:

Heart Disease OW

Vermillion Announces Issuance Of Patent For Peripheral Artery Disease: Vermillion, Inc. (Nasdaq: VRML), a molecu... http://bit.ly/gcAIwN

1 year ago...

Retweet

Favorite

Also Shared By:

USPTO issues notice of allowance for Vermillion's PAD biomarker patent

news-medical.net — “Vermillion, Inc., a molecular diagnostics company, today announced that the United States Patent and Trademark Office has issued a notice of allowance for a patent entitled "Beta-2 microglobulin as a Biomarker for Peripheral Artery Disease."” View full resource at news-medical.net